<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="http://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:voc="urn:hl7-org:v3/voc" xmlns="urn:hl7-org:v3" xsi:schemaLocation="urn:hl7-org:v3 http://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="c98209e6-a607-a8c9-9db3-529b9a59752d"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>
      <content styleCode="bold">Clocortolone Pivalate Cream, 0.1%</content>
   </title>
   <effectiveTime value="20140224"/>
   <setId root="1eae193c-5cfd-5db1-344a-c951e2c9eff8"/>
   <versionNumber value="2"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="802315887" root="1.3.6.1.4.1.519.1"/>
            <name>Dr. Reddy's Laboratories Inc</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="832224526" root="1.3.6.1.4.1.519.1"/>
                        <name>DPT Laboratories Ltd.</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="manufacture"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="43598-341" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="analysis"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="43598-341" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="a1810003-f4d0-595a-fb82-7c178fa9a95d"/>
               <code code="48780-1" displayName="SPL PRODUCT DATA ELEMENTS SECTION" codeSystem="2.16.840.1.113883.6.1"/>
               <effectiveTime value="20140224"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="43598-341" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>clocortolone pivalate</name>
                        <formCode code="C28944" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CREAM"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>clocortolone pivalate</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="0.001"/>
                              <denominator unit="g" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="QBL8IZH14X" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>clocortolone pivalate</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="N8ZUB7XE0H" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>clocortolone</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="4T6H12BN9U" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>PETROLATUM</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="T5L8T28FGP" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>MINERAL OIL</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="2KR89I4H1Y" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>STEARYL ALCOHOL</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="13A4J4NH9I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POLYOXYL 40 STEARATE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="HHT01ZNK31" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CARBOMER HOMOPOLYMER TYPE B</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="7FLD91C86K" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>EDETATE DISODIUM</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM HYDROXIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="A2I8C7HI9T" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>METHYLPARABEN</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="Z8IX2SC1OH" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>PROPYLPARABEN</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="g" value="30"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43174" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, PUMP"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code codeSystem="2.16.840.1.113883.6.69" code="43598-341-30"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                              </asContent>
                           </containerPackagedProduct>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator unit="g" value="45"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C42794" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TUBE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code codeSystem="2.16.840.1.113883.6.69" code="43598-341-45"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                              </asContent>
                           </containerPackagedProduct>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator unit="g" value="75"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43174" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, PUMP"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code codeSystem="2.16.840.1.113883.6.69" code="43598-341-75"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                              </asContent>
                           </containerPackagedProduct>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator unit="g" value="90"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C42794" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TUBE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code codeSystem="2.16.840.1.113883.6.69" code="43598-341-90"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                              </asContent>
                           </containerPackagedProduct>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA017765" root="2.16.840.1.113883.3.150"/>
                           <code code="C73605" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA authorized generic"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20140217"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38304" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TOPICAL"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <component>
                  <section>
                     <id root="b322a5ef-85b5-4dc9-b09b-2114c4da43f5"/>
                     <code code="42229-5" displayName="SPL UNCLASSIFIED SECTION" codeSystem="2.16.840.1.113883.6.1"/>
                     <effectiveTime value="20140207"/>
                     <component>
                        <observationMedia ID="MM609915794789">
                           <text>structure</text>
                           <value xsi:type="ED" mediaType="image/jpeg">
                              <reference value="structure.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                     <component>
                        <observationMedia ID="MM452276916914">
                           <text>bottle</text>
                           <value xsi:type="ED" mediaType="image/jpeg">
                              <reference value="bottle.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                     <component>
                        <observationMedia ID="MM590912852677">
                           <text>carton</text>
                           <value xsi:type="ED" mediaType="image/jpeg">
                              <reference value="carton.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="_047325e8-1cf3-f384-b623-1bbf50e5f029">
               <id root="ec441938-a14a-e46e-550c-db9e1de67a3c"/>
               <code code="42229-5" displayName="SPL UNCLASSIFIED SECTION" codeSystem="2.16.840.1.113883.6.1"/>
               <title/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Rx Only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">FOR TOPICAL DERMATOLOGIC USE ONLY-</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">NOT FOR OPTHALMIC, ORAL, OR INTRAVAGINAL USE.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">WARNING: KEEP OUT OF REACH OF CHILDREN</content>
                  </paragraph>
               </text>
               <effectiveTime value="20140207"/>
            </section>
         </component>
         <component>
            <section ID="_c2d8674d-c1ff-2afc-db41-643d96bf9aa2">
               <id root="e1e9d624-f86a-bf1c-483c-49c43b05261b"/>
               <code code="34089-3" displayName="DESCRIPTION SECTION" codeSystem="2.16.840.1.113883.6.1"/>
               <title>DESCRIPTION</title>
               <text>
                  <paragraph>Clocortolone Pivalate Cream 0.1% contains the medium potency topical corticosteroid, clocortolone pivalate, in a specially formulated water-washable emollient cream base consisting of purified water, white petrolatum, mineral oil, stearyl alcohol, polyoxyl 40 stearate,carbomer 934P, edetate disodium, sodium hydroxide, with methylparaben and propylparaben as preservatives.</paragraph>
                  <paragraph>Chemically, clocortolone pivalate is 9-chloro-6α-fluoro-11β,21-dihydroxy-16α methylpregna-1,4-diene-3, 20-dione 21-pivalate.Its structure is as follows:α-fluoro-11β,21-dihydroxy-16α methylpregna-1,4-diene-3, 20-dione 21-pivalate.Its structure is as follows:α methylpregna-1,4-diene-3, 20-dione 21-pivalate.Its structure is as follows:</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM609915794789"/>
                  </paragraph>
               </text>
               <effectiveTime value="20140207"/>
            </section>
         </component>
         <component>
            <section ID="CLINICAL_PHARMACOLOGY">
               <id root="f4ecb04e-1969-5840-294a-6206cd56468d"/>
               <code code="34090-1" displayName="CLINICAL PHARMACOLOGY SECTION" codeSystem="2.16.840.1.113883.6.1"/>
               <title>CLINICAL PHARMACOLOGY</title>
               <text>
                  <paragraph>Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions.</paragraph>
                  <paragraph>The mechanism of anti-inflammatory activity of the topical corticosteroidsis unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man.</paragraph>
                  <paragraph>
                     <content styleCode="italics">Pharmacokinetics</content>: The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle, the integrity of the epidermal barrier, and the use of occlusive dressings.The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle, the integrity of the epidermal barrier, and the use of occlusive dressings.</paragraph>
                  <paragraph>Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increasepercutaneous absorption. Occlusive dressings substantially increase the percutaneous absorption of topical corticosteroids. Thus, occlusive dressings may be a valuable therapeutic adjunct for treatment of resistant dermatoses.</paragraph>
                  <paragraph>(See <content styleCode="bold">
                        <linkHtml href="#_aa3b8597-940b-ca71-654b-4f4dddf44826">DOSAGE AND ADMINISTRATION</linkHtml>
                     </content>).<content styleCode="bold"/>
                  </paragraph>
                  <paragraph>Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to systemically administered corticosteroids. Corticosteroids are bound to plasma proteins in varying degrees. Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys. Some of the topical corticosteroids and their metabolites are also excreted into the bile.</paragraph>
                  <paragraph/>
               </text>
               <effectiveTime value="20140207"/>
            </section>
         </component>
         <component>
            <section ID="_1117ba0c-2aab-7eef-ff1a-3b04021f5df1">
               <id root="608aac0d-ccc6-3dcb-113a-7a14658b10b2"/>
               <code code="34067-9" displayName="INDICATIONS &amp; USAGE SECTION" codeSystem="2.16.840.1.113883.6.1"/>
               <title>INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.</paragraph>
               </text>
               <effectiveTime value="20140207"/>
            </section>
         </component>
         <component>
            <section ID="CONTRAINDICATIONS">
               <id root="cb0e4c8e-e971-8b98-5bb2-3187e105dc35"/>
               <code code="34070-3" displayName="CONTRAINDICATIONS SECTION" codeSystem="2.16.840.1.113883.6.1"/>
               <title>CONTRAINDICATIONS</title>
               <text>
                  <paragraph>Topical corticosteroids are contraindicated in those patients with ahistory of hypersensitivity to any of the components of the preparation.</paragraph>
               </text>
               <effectiveTime value="20140207"/>
            </section>
         </component>
         <component>
            <section ID="PRECAUTIONS">
               <id root="ceb86f2f-8eaf-ef73-31fd-7bb1e27bab46"/>
               <code code="42232-9" displayName="PRECAUTIONS SECTION" codeSystem="2.16.840.1.113883.6.1"/>
               <title>PRECAUTIONS</title>
               <text>
                  <paragraph>
                     <content styleCode="italics"/>
                  </paragraph>
               </text>
               <effectiveTime value="20140207"/>
               <component>
                  <section ID="_0f8e554d-6058-7b4d-76ae-7d09b60a7be2">
                     <id root="827ff3fa-73a0-7c4f-1e9f-e0fd53420202"/>
                     <code code="42229-5" displayName="SPL UNCLASSIFIED SECTION" codeSystem="2.16.840.1.113883.6.1"/>
                     <title>General</title>
                     <text>
                        <paragraph>Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing’s syndrome, hyperglycemia, and glucosuriain some patients.</paragraph>
                        <paragraph>Conditions which augment systemic absorption include the application of the more potent steroids, use over large surface areas, prolonged use, and the addition of occlusive dressings.</paragraph>
                        <paragraph>Therefore, patients receiving a large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests. If HPA axis suppression is noted, an attempt should be made to withdraw the drug,to reduce the frequency of application, or to substitute a less potentsteroid.</paragraph>
                        <paragraph>Recovery of HPA axis function is generally prompt and complete upon discontinuation of the drug. In frequently, signs and symptoms of steroid withdrawal may occur, requiring supplemental systemic corticosteroids.</paragraph>
                        <paragraph>Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity.(See <content styleCode="bold">
                              <linkHtml href="#_6cfee687-a7e4-e3e3-bbc0-6ccb98093a6d">PRECAUTIONS</linkHtml>
                           </content>
                           <linkHtml href="#_6cfee687-a7e4-e3e3-bbc0-6ccb98093a6d">
                              <footnote>
                                 <content styleCode="bold">-</content>
                              </footnote>Pediatric Use</linkHtml>).</paragraph>
                        <paragraph>If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted.</paragraph>
                        <paragraph>In the presence of dermatological infections, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection has been adequately controlled.</paragraph>
                        <paragraph/>
                     </text>
                  </section>
               </component>
               <component>
                  <section ID="_ae98c0ff-04a9-2648-1af6-982edf947be6">
                     <id root="2b54b0d2-92a6-3d47-54bd-815530dbb5ea"/>
                     <code code="42229-5" displayName="SPL UNCLASSIFIED SECTION" codeSystem="2.16.840.1.113883.6.1"/>
                     <title>Information for the Patient</title>
                     <text>
                        <paragraph>Patients using topical corticosteroids should receive the following information and instructions:</paragraph>
                        <paragraph>1. This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes.</paragraph>
                        <paragraph>2. Patients should be advised not to use this medication for any disorder other than for which it was prescribed.</paragraph>
                        <paragraph>3. The treated skin area should not be bandaged or otherwise covered or wrapped as to be occlusive unless directed by the physician.</paragraph>
                        <paragraph>4. Patients should report any signs of local adverse reactionse specially under occlusive dressing.</paragraph>
                        <paragraph>5. Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area, as these garments may constitute occlusive dressings.</paragraph>
                     </text>
                  </section>
               </component>
               <component>
                  <section ID="_18bb6b75-4079-6b56-1839-372b0dfbafbb">
                     <id root="90299b81-363b-7e8c-1565-57d15c01efc7"/>
                     <code code="42229-5" displayName="SPL UNCLASSIFIED SECTION" codeSystem="2.16.840.1.113883.6.1"/>
                     <title>Laboratory Tests</title>
                     <text>
                        <paragraph>The following tests may be helpful in evaluating the HPA axis suppression:</paragraph>
                        <paragraph>Urinary free cortisol test</paragraph>
                        <paragraph>ACTH stimulation test</paragraph>
                     </text>
                  </section>
               </component>
               <component>
                  <section ID="_962764a9-2495-ba16-2953-ddd49a911e9a">
                     <id root="7e6c7b6a-250f-0645-186d-931f01f8a6f6"/>
                     <code code="42229-5" displayName="SPL UNCLASSIFIED SECTION" codeSystem="2.16.840.1.113883.6.1"/>
                     <title>Carcinogenesis, Mutagenesis, and Impairment of Fertility</title>
                     <text>
                        <paragraph>Long-termanimal studies have not been performed to evaluate the carcinogenic potentialor the effect on fertility of topical corticosteroids.</paragraph>
                        <paragraph>Studies to determine mutagenicity with prednisolone and hydrocortisone have revealed negative results.</paragraph>
                     </text>
                  </section>
               </component>
               <component>
                  <section ID="_16e3ebc3-7884-5290-52ef-e583efae9d21">
                     <id root="ae26e1fa-8156-605d-4e4c-62a1691391d6"/>
                     <code code="42229-5" displayName="SPL UNCLASSIFIED SECTION" codeSystem="2.16.840.1.113883.6.1"/>
                     <title>Pregnancy Category C</title>
                     <text>
                        <paragraph>Corticosteroids are generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels. The more potent corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.</paragraph>
                     </text>
                  </section>
               </component>
               <component>
                  <section ID="_38e33643-9a47-9802-63a4-2a38d0519906">
                     <id root="5422c407-7d47-d4eb-ac66-66851a9a38ec"/>
                     <code code="42229-5" displayName="SPL UNCLASSIFIED SECTION" codeSystem="2.16.840.1.113883.6.1"/>
                     <title>Nursing Mothers</title>
                     <text>
                        <paragraph>It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Systemically administered corticosteroids are secreted into breast milk in quantities not likely to have deleterious effect on the infant. Nevertheless, caution should be exercised when topical corticosteroids are administered to a nursing woman.</paragraph>
                     </text>
                  </section>
               </component>
               <component>
                  <section ID="_6cfee687-a7e4-e3e3-bbc0-6ccb98093a6d">
                     <id root="23cca787-bf5b-b39f-be92-b0e1abc4ab6c"/>
                     <code code="42229-5" displayName="SPL UNCLASSIFIED SECTION" codeSystem="2.16.840.1.113883.6.1"/>
                     <title>Pediatric Use</title>
                     <text>
                        <paragraph>Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing’s syndrome than mature patients because of a larger skin surface area body weight ratio.</paragraph>
                        <paragraph>Hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing’s syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids. Manifestations of adrenal suppressionin children include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to ACTH stimulation. Manifestations of intracranial hypertension include bulging fontanelles,headaches, and bilateral papilledema.</paragraph>
                        <paragraph>Administration of topical corticosteroids to children should be limited to the least amount compatible with an effective therapeutic regimen.Chronic corticosteroid therapy may interfere with the growth and development of children.</paragraph>
                     </text>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="_d6426b43-798a-e393-0ec8-dcb526dac465">
               <id root="e43a676a-bb73-58e8-e28a-d959122ca51a"/>
               <code code="34084-4" displayName="ADVERSE REACTIONS SECTION" codeSystem="2.16.840.1.113883.6.1"/>
               <title>ADVERSE REACTIONS</title>
               <text>
                  <paragraph>The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence:</paragraph>
                  <paragraph>Burning</paragraph>
                  <paragraph>Itching</paragraph>
                  <paragraph>Irritation</paragraph>
                  <paragraph>Dryness</paragraph>
                  <paragraph>Folliculitis</paragraph>
                  <paragraph>Hypertrichosis</paragraph>
                  <paragraph>Acneform eruptions</paragraph>
                  <paragraph>Hypopigmentation</paragraph>
                  <paragraph>Perioral dermatitis</paragraph>
                  <paragraph>Allergic contact dermatitis</paragraph>
                  <paragraph>Maceration of the skin</paragraph>
                  <paragraph>Secondary infection</paragraph>
                  <paragraph>Skin atrophy</paragraph>
                  <paragraph>Striae</paragraph>
                  <paragraph>Miliaria</paragraph>
               </text>
               <effectiveTime value="20140207"/>
            </section>
         </component>
         <component>
            <section ID="_63949f7a-9ce3-8f46-8d96-f8ddee839157">
               <id root="d7277e79-3b0a-87e0-176e-eb45aac34bdb"/>
               <code code="34088-5" displayName="OVERDOSAGE SECTION" codeSystem="2.16.840.1.113883.6.1"/>
               <title>OVERDOSAGE</title>
               <text>
                  <paragraph>Topically applied corticosteroids can be absorbed in sufficient amountsto produce systemic effects (see <content styleCode="bold">
                        <linkHtml href="#PRECAUTIONS">PRECAUTIONS</linkHtml>
                     </content>).</paragraph>
               </text>
               <effectiveTime value="20140207"/>
            </section>
         </component>
         <component>
            <section ID="_aa3b8597-940b-ca71-654b-4f4dddf44826">
               <id root="04d2496d-e01d-88d7-a239-c7c335e3cebe"/>
               <code code="34068-7" displayName="DOSAGE &amp; ADMINISTRATION SECTION" codeSystem="2.16.840.1.113883.6.1"/>
               <title>DOSAGE AND ADMINISTRATION</title>
               <text>
                  <paragraph>Apply Clocortolone Pivalate Cream 0.1% sparingly to the affected areas three times a day and rub in gently.</paragraph>
                  <paragraph>Occlusive dressings may be used for the management of psoriasis orrecalcitrant conditions.</paragraph>
                  <paragraph>If an infection develops, the use of occlusive dressings should be discontinued and appropriate anti-microbial therapy instituted.</paragraph>
               </text>
               <effectiveTime value="20140207"/>
            </section>
         </component>
         <component>
            <section ID="_c9a6608d-1c05-46b9-092a-c50f092856fb">
               <id root="54b64401-db46-7290-d69b-c2b998c0a447"/>
               <code code="34069-5" displayName="HOW SUPPLIED SECTION" codeSystem="2.16.840.1.113883.6.1"/>
               <title>HOW SUPPLIED</title>
               <text>
                  <paragraph>Clocortolone Pivalate Cream 0.1% is supplied in 30 gram and 75 gram pump bottles, 45 gram and 90 gram tubes.</paragraph>
                  <table border="1" cellpadding="4" width="85%">
                     <tbody>
                        <tr>
                           <td>30 gram pump bottle</td>
                           <td>NDC 43598-341-30</td>
                        </tr>
                        <tr>
                           <td>75 gram pump bottle</td>
                           <td>NDC 43598-341-75</td>
                        </tr>
                        <tr>
                           <td>45 gram tube</td>
                           <td>NDC 43598-341-45</td>
                        </tr>
                        <tr>
                           <td>90 gram tube</td>
                           <td>NDC 43598-341-90</td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph/>
               </text>
               <effectiveTime value="20140207"/>
            </section>
         </component>
         <component>
            <section ID="_10167d7c-84a2-15e7-7acc-dab237efbfdb">
               <id root="9648aa0f-aced-a58e-3961-e9363cda2d65"/>
               <code code="42229-5" displayName="SPL UNCLASSIFIED SECTION" codeSystem="2.16.840.1.113883.6.1"/>
               <title>STORAGE</title>
               <text>
                  <paragraph>Store Clocortolone Pivalate Cream 0.1% between 15° and 30° C(59° and 86° F). Avoid freezing.</paragraph>
                  <paragraph>Distributed by:</paragraph>
                  <paragraph>Dr. Reddy’s Laboratories, Inc.</paragraph>
                  <paragraph>Princeton, NJ 08540</paragraph>
                  <paragraph>Manufactured by:</paragraph>
                  <paragraph>DPT Laboratories, Ltd.</paragraph>
                  <paragraph>San Antonio. Texas 78215</paragraph>
                  <paragraph/>
               </text>
               <effectiveTime value="20140207"/>
            </section>
         </component>
         <component>
            <section ID="_85a1319d-ba3b-5188-cc7d-7eb71023e4b3">
               <id root="0dba83bf-8618-2b63-335f-c28bc02c054c"/>
               <code code="51945-4" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" codeSystem="2.16.840.1.113883.6.1"/>
               <title>PACKAGE LABEL PRINCIPAL DISPLAY PANEL SECTION</title>
               <text>
                  <paragraph>30 gram Bottle Label:</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM452276916914"/>
                  </paragraph>
               </text>
               <effectiveTime value="20140207"/>
            </section>
         </component>
         <component>
            <section ID="_a884cab8-35a3-09c7-aa1e-164811c6e1d1">
               <id root="15a1f39d-4d3f-75d5-a835-d1fa4cc4df8b"/>
               <code code="51945-4" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" codeSystem="2.16.840.1.113883.6.1"/>
               <title/>
               <text>
                  <paragraph>30 gram Bottle Carton Label</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM590912852677"/>
                  </paragraph>
               </text>
               <effectiveTime value="20140207"/>
            </section>
         </component>
      </structuredBody>
   </component>
</document>